Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis

Summary

The purpose of this study is to assess the safety and efficacy of oral deucravacitinib in participants with moderate to severe ulcerative colitis (UC).

Timeline

Start

2019-07-01

Primary completion

2021-06-13

Completion

2023-04-04

Outcome

Missed primary endpoint

registry analysis (superiority test); Treatment vs Placebo; p = 0.5935; Odds Ratio (OR) 0.9 (95% CI 0.3 to 2.4); Stratified Cochran-Mantel-Haenszel NCT03934216 ↗

Drugs

Indications